The properties of Aescin in supplements
|TBS Ingredient ID (TBSI ID):||IS38EA50|
|Escin, Escin Ib, EscinI B, Escine Ib, beta-Escin|
| PubChem CID: |
U.S. National Library of Medicine (PubChem)
| InChI Key: |
International Chemical Identifier hash (InChIKey) computed from chemical structure using the International Union of Pure and Applied Chemistry (IUPAC) standard
| CAS: |
A proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS)
| EC Number: |
A seven-digit regulatory identifier currently assigned by the European Chemicals Agency (ECHA) known as a European Community (EC) number
| ChEBI: |
Chemical Entities of Biological Interest (ChEBI) - Dictionary of molecular entities focused on "small" chemical compounds. ChEBI is part of the EMBL-European Bioinformatics Institute.
Aescin or escin is a mixture of saponins with anti-inflammatory, vasoconstrictor and vasoprotective effects found in Aesculus hippocastanum (the horse chestnut). Aescin is the main active compound in horse chestnut, and is responsible for most of its medicinal properties.
Evidence suggests that aescin is a safe and effective treatment for short-term treatment of chronic venous insufficiency.
Aescin has been shown to eliminate oedema and reduce exudation. It antagonizes the effect of bradykinin, although it is not a direct bradykinin antagonist.